A detailed history of Close Asset Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Close Asset Management LTD holds 10,003 shares of ABT stock, worth $1.28 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,003
Holding current value
$1.28 Million
% of portfolio
0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$111.93 - $119.39 $1.12 Million - $1.19 Million
10,003 New
10,003 $1.13 Million
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $26,189 - $29,234
-260 Reduced 2.15%
11,853 $1.23 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $81 Million - $89.4 Million
-739,414 Reduced 98.39%
12,113 $1.38 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $66.9 Million - $81.8 Million
741,285 Added 7237.7%
751,527 $82.7 Million
Q3 2023

Oct 11, 2023

BUY
$95.53 - $114.62 $14,042 - $16,849
147 Added 1.46%
10,242 $992,000
Q2 2023

Jul 26, 2023

BUY
$100.78 - $112.29 $35,273 - $39,301
350 Added 3.59%
10,095 $1.1 Million
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $119,912 - $141,144
1,238 Added 14.55%
9,745 $987,000
Q4 2022

Jan 27, 2023

BUY
$95.06 - $111.52 $9,410 - $11,040
99 Added 1.18%
8,507 $934,000
Q2 2022

Jul 29, 2022

BUY
$102.07 - $123.37 $53,790 - $65,015
527 Added 6.69%
8,408 $915,000
Q4 2021

Jan 27, 2022

SELL
$115.53 - $141.46 $1,732 - $2,121
-15 Reduced 0.19%
7,881 $1.11 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $97,994 - $108,410
-840 Reduced 9.62%
7,896 $933,000
Q2 2021

Jul 27, 2021

BUY
$105.79 - $124.53 $30,150 - $35,491
285 Added 3.37%
8,736 $1.01 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $120,812 - $142,335
1,110 Added 15.12%
8,451 $1.01 Million
Q4 2020

Jan 22, 2021

BUY
$105.0 - $114.42 $63,105 - $68,766
601 Added 8.92%
7,341 $804,000
Q3 2020

Oct 30, 2020

SELL
$91.64 - $111.29 $38,030 - $46,185
-415 Reduced 5.8%
6,740 $733,000
Q2 2020

Jul 28, 2020

BUY
$76.57 - $98.0 $11,485 - $14,700
150 Added 2.14%
7,155 $654,000
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $99,569 - $145,598
1,585 Added 29.24%
7,005 $552,000
Q4 2019

Jan 22, 2020

BUY
$78.51 - $87.4 $51,031 - $56,810
650 Added 13.63%
5,420 $471,000
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $75,292 - $81,640
-920 Reduced 16.17%
4,770 $399,000
Q2 2019

Aug 01, 2019

BUY
$72.88 - $85.0 $94,015 - $109,650
1,290 Added 29.32%
5,690 $477,000
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $250,708 - $303,107
3,786 Added 616.61%
4,400 $352,000
Q4 2018

Jan 28, 2019

SELL
$65.56 - $74.27 $248,210 - $281,186
-3,786 Reduced 86.05%
614 $52,000
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $267,564 - $322,784
4,400 New
4,400 $323,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.